Click here to access Business Weekly's ten year archive of East of England 'Life Sciences' articles
|
|
Cancer boost from Cambridge University's US alliance |
|
Written by Tony Quested
|
|
Wednesday, 09 April 2008 |
 World-leading science from the University of Cambridge could
revolutionise the treatment of cancer and infectious diseases through
an alliance with a specialist company in the United States.
|
|
|
Asterand's shares fall despite progress |
|
Written by Ben Fountain
|
|
Friday, 04 April 2008 |
 A significant reduction in losses at human tissue specialist, Asterand failed to impress the market, with what on the surface look to be a positive set of results precipitating a 12 per cent fall in the company's share price.
|
|
|
Drug manufacturer chooses Bedford |
|
Written by News Desk
|
|
Wednesday, 02 April 2008 |
|
Bedford will become the UK hub
for one of the world's largest
manufacturers of drugs that
combat bacterial infections, cardiovascular disease and tuberculosis, following a new contract
win by Bedford-based healthcare logistics firm, Movianto UK.
|
|
|
Pharmacos feel the squeeze, says consultancy |
|
Written by Lautaro Vargas
|
|
Wednesday, 02 April 2008 |
An often misguided and antiquated perception of the capabilities of the
outsourcing industry is preventing a global pharma industry showing
signs of decline from relieving much of the pressure it is under
according to local technology consultancy, PA Consulting.
|
|
|
New Indian owner to invest in Cambridge biotech enterprise |
|
Written by Tony Quested
|
|
Wednesday, 02 April 2008 |
India’s acquisition-hungry tiger economy is promising to burn brightly for Cambridge’s Life Sciences cluster following a significant takeover. Dr. Reddy’s Laboratories in Hyderabad is buying US giant Dow Chemical’s Cambridge Science Park business Chirotech and other interests.
|
|
|
NovaThera signs agreement with Hong Kong company |
|
Written by News Desk
|
|
Wednesday, 02 April 2008 |
|
Cambridge company NovaThera
Ltd and Hong Kong based MediHealth Ltd have signed an exclusive agreement for the scaled
up production and distribution of
NovaPod? systems.
|
|
|
VetCell moves into multi-billion dollar North American market |
|
Written by Ben Fountain
|
|
Friday, 28 March 2008 |
VetCell Bioscience, the Newmarket-based pioneer of stem cell technology
to the world of animal health has announced a dual-pronged incursion
into the North American market.
|
|
|
Acambis extends its £20m JE vaccine deal |
|
Written by Sam Fountain
|
|
Thursday, 27 March 2008 |
|
World-leading vaccine maker, Acambis has announced an extension to last year's £20m licensing deal for its Japanese Encephalitis vaccine, ChimeriVax-JE with the vaccines division of the global pharma giant, sanofi-aventis.
|
|
|
Celsis heats up fight against Hepatitis |
|
Written by Sam Fountain
|
|
Thursday, 27 March 2008 |
|
Rapid laboratory analysis group, Celsis has announced an agreement with US-based pharmaceutical discovery company, Apath to evaluate drug candidates to combat the Hep C virus.
|
|
|
Lab21 unveils first part of "aggressive acquisition strategy" |
|
Written by Ben Fountain
|
|
Tuesday, 25 March 2008 |
|
Cambridge diagnostics company Lab21 has started off close to home in
what it says will be an "aggressive" Europe-wide acquisition strategy
in snapping up independent clinical lab, NPTech.
|
|
|
|
<< Start < Prev 1 2 3 4 5 6 7 8 9 Next > End >>
|
| Results 52 - 68 of 140 |
Life Sciences 
